1. Home
  2. BOKF vs HALO Comparison

BOKF vs HALO Comparison

Compare BOKF & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOK Financial Corporation

BOKF

BOK Financial Corporation

HOLD

Current Price

$121.08

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.46

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOKF
HALO
Founded
1910
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BOKF
HALO
Price
$121.08
$68.46
Analyst Decision
Hold
Buy
Analyst Count
11
12
Target Price
$117.82
$73.33
AVG Volume (30 Days)
283.1K
2.6M
Earning Date
01-16-2026
11-03-2025
Dividend Yield
2.08%
N/A
EPS Growth
15.51
56.68
EPS
8.40
4.74
Revenue
$2,107,957,000.00
$1,242,852,000.00
Revenue This Year
$7.21
$34.83
Revenue Next Year
$6.33
$24.84
P/E Ratio
$14.45
$14.39
Revenue Growth
5.14
31.19
52 Week Low
$85.08
$46.26
52 Week High
$122.04
$79.50

Technical Indicators

Market Signals
Indicator
BOKF
HALO
Relative Strength Index (RSI) 70.50 58.01
Support Level $118.49 $61.23
Resistance Level $122.04 $69.28
Average True Range (ATR) 2.14 1.98
MACD 0.17 0.62
Stochastic Oscillator 91.99 91.06

Price Performance

Historical Comparison
BOKF
HALO

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: